Lunai Bioworks Inc. (LNAI) Form 8-K — Oct 22, 2026
Lunai Bioworks (Nasdaq: LNAI) received a Nasdaq determination on October 21, 2026 that it no longer complies with the $2.5 million minimum stockholders' equity rule, having reported a $9.0 million stockholders' deficit for fiscal 2026. As a company under a mandatory Hearings Panel Monitor, it is ineligible for a compliance plan, and Nasdaq staff determined to delist the stock. Trading in LNAI will be suspended at the open on October 30, 2026. The Board chose not to request a hearing and instead approved voluntary withdrawal from Nasdaq, filing a Form 25 on or about November 2 with delisting effective around November 12.
Key figures
- Form 25 filing date
- on or about 2026-11-02
- Trading suspension date
- 2026-10-30
- Delisting effective date
- on or about 2026-11-12
- Board size after resignation
- 3
- Minimum stockholders equity required
- 2500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.